M42, a global health leader powered by artificial intelligence (AI), technology and genomics, has been recognized by the Ministry of Health and Prevention (MoHAP)
Explore MoreM42 is strengthening its UAE healthcare portfolio with 100 per cent ownership of United Eastern Medical Services’ assets, while Olive Rock Partners takes 100 per cent ownership of HealthPlus IVF & Women’s Health Abu Dhabi
Explore MoreLaunch groundbreaking effort to advance precision medicine by delivering pharmacogenomic insight at the point of care
Explore MoreM42 formalizes its 12-year presence in the Kingdom at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare
Explore MoreM42 announced a strategic partnership with Human Life CORD Japan Inc. (HLC)
Landmark procedure strengthens the UAE’s position in advanced fetal care and complex prenatal interventions.
M42, a global health leader powered by AI, technology and genomics, and its world leading renal care business, Diaverum, today a...
A study issued by M42 in partnership with the Department of Health – Abu Dhabi demonstrates how genomics enables prevention of v...
Abu Dhabi has taken a major step toward transforming how disease is detected, prevented and treated, with the inauguration of th...
Strategic alignment announced at the Dubai World Health Expo 2026 combines global healthcare expertise with digital health innov...
